ANIK Financials: Anika Therapeutics Inc AI Analysis



Financials

ANIK Financial

Anika Therapeutics Inc

$14.54

-1.55%

$-0.23

At close: May 11, 16:00:00 GMT-4

$14.54

Post-market: May 11, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$14.77

Open

$14.75

Day's Range

$14.22 - $14.8

52 week range

$7.87 - $16.24

Volume

65.5K

Avg.Volume

140.4K

Dividend yield

EPS (TTM)

-0.76

Market Cap

$194.8M

What is ANIK?

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. The company is headquartered in Bedford, Massachusetts and currently employs 288 full-time employees. The firm is leveraging its core expertise in hyaluronic acid and implant solutions. The company partners with clinicians to provide minimally invasive products that restore active living for people around the world. The company is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. The company is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.

Features

Markets

News

Income

Balance sheet

Cash flow

Annual

Quarterly

ANIK Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
Revenue	116	29	30	27	28	26
Revenue Growth (YoY)	-15%	12%	0%	-28.99%	-32%	-35%
Cost of Revenue	48	10	11	12	13	11
Gross Profit	68	18	19	15	14	14
Selling, General & Admin	52	16	12	11	12	12
Research & Development	26	6	6	6	6	6
Operating Expenses	78	22	18	18	18	18
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-10	-4	0	-2	-3	-3
Income Tax Expense	0	0	-1	0	0	0
Net Income	-11	-5	0	-2	-3	-4
Net Income Growth	-80%	25%	-100%	-93%	--	0%
Shares Outstanding (Diluted)	13.53	13.53	14.27	14.41	14.36	14.29
Shares Change (YoY)	-5%	-5%	-2%	-2%	-3%	-3%
EPS (Diluted)	-0.81	-0.37	0.02	-0.16	-0.27	-0.34
EPS Growth	-80%	10%	-101%	-92%	4,476%	11%
Free Cash Flow	1	-6	3	4	-1	-2
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	58.62%	62.06%	63.33%	55.55%	50%	53.84%
Operating Margin	-8.62%	-10.34%	0%	-11.11%	-14.28%	-15.38%
Profit Margin	-9.48%	-17.24%	0%	-7.4%	-10.71%	-15.38%
Free Cash Flow Margin	0.86%	-20.68%	10%	14.81%	-3.57%	-7.69%
EBITDA	-5	-2	1	-2	-3	-3
EBITDA Margin	-4.31%	-6.89%	3.33%	-7.4%	-10.71%	-11.53%
D&A For EBITDA	5	1	1	1	1	1
EBIT	-10	-3	0	-3	-4	-4
EBIT Margin	-8.62%	-10.34%	0%	-11.11%	-14.28%	-15.38%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Follow-Up Questions

What are Anika Therapeutics Inc's key financial statements?



According to the latest financial statement (Form-10K), Anika Therapeutics Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for ANIK?



Anika Therapeutics Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Anika Therapeutics Inc's revenue broken down by segment or geography?



Anika Therapeutics Inc largest revenue segment is Original Equipment Manufacturer Channel, at a revenue of 64,406,000 in the most earnings release.For geography, United States is the primary market for Anika Therapeutics Inc, at a revenue of 70,058,000.

Is Anika Therapeutics Inc profitable?



no, according to the latest financial statements, Anika Therapeutics Inc has a net loss of $0

Does Anika Therapeutics Inc have any liabilities?



no, Anika Therapeutics Inc has liability of 0

How many outstanding shares for Anika Therapeutics Inc?



Anika Therapeutics Inc has a total outstanding shares of 0

Anika Therapeutics Inc (ANIK) Financial

ANIK Stock Price Chart